Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS · BSE: 544222 · Pharmaceuticals & Biotechnology · 8 announcements

Share price: ₹819.55
Market cap: ₹12,899 Cr
Revenue (annual): ₹4,359 Cr
Net profit (annual): ₹255.2 Cr
P/E (TTM): 44.2×Sector 50.4×
Promoter holding: 75.26%+0.00% QoQ
FII holding: 1.91%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 2 Other Announcement 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

8 Aug 2026 15:47 IST NSE

Financial ResultsAlfa Alert

Akums Drugs & Pharmaceuticals Q1 FY27 Results: Net Profit ₹101 Cr, Up 56.1% YoY

Akums Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹1,167 Cr (+13.9% YoY) and net profit of ₹101 Cr (+56.1% YoY) for Q1 FY27.

Key figure: Net profit ₹101 Cr · +56.1% YoY

Open full results → Read the filing ↗

14 May 2026 13:34 IST NSE

Financial Results

Akums Drugs & Pharmaceuticals Q4 FY26 Results: Net Profit ₹81.3 Cr, Down 45.7% YoY

Akums Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹1,158 Cr (+9.7% YoY) and net profit of ₹81.3 Cr (-45.7% YoY) for Q4 FY26.

Key figure: Net profit ₹81.3 Cr · -45.7% YoY

Open full results → Read the filing ↗